Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 20132014 and 20142015
Maternal influenza vaccination is increasingly recognized to protect infants from influenza infection in their first 6 months. We used the screening method to estimate vaccine effectiveness (VE) against laboratory-confirmed influenza in infants in England.
CONCLUSION: There are a variety of factors influencing women when deciding on antenatal influenza vaccination. Further studies are needed to expand on the findings of this small local study in order to be able to improve vaccination uptake through empathetic delivery of evidence-based recommendations. PMID: 31778371 [PubMed - in process]
This study explored knowledge, acceptance and uptake of influenza vaccine among pregnant woman, and examined factors underlying the decision to vaccinate, barriers to vaccination, and patient-provider communication regarding influenza vaccinations during prenatal care.
To assess the safety and immunogenicity of simultaneous versus sequential tetanus, diphtheria, acellular pertussis vaccine (Tdap) and quadrivalent inactivated influenza vaccine (IIV4) in pregnant woman and transplacental antibody transfer at delivery.
Authors: Shukralla H, Coory M PMID: 31763697 [PubMed - as supplied by publisher]
This article aims to identify the prevalence and factors associated with influenza vaccination in pregnant women. This is a cross-sectional study conducted in a municipality in the southernmost region of Brazil, which included all women giving birth in 2016. The outcome was having received the vaccine against influenza during pregnancy. Sociodemographic, behavioral and prenatal care characteristics and morbidities were analyzed. The analysis included sample description, the prevalence of vaccination for each independent variable and a multivariate analysis. Two thousand six hundred ninety-four pregnant women were interview...
Most US mothers-to-be (65%) have not been vaccinated for both influenza and pertussis, according to a CDC report.
Abstract Current vaccination coverage rates in Latin America and the Caribbean (LAC) are lower than the region-wide rates set by the Pan American Health Organization. To improve vaccination uptake, it is crucial to identify barriers to vaccination. We conducted a systematic literature review to identify the key barriers to vaccination in the LAC region, and to classify and quantify factors affecting vaccination coverage using the barrier categories outlined by the Strategic Advisory Group of Experts (SAGE) working group. We mapped knowledge gaps in the understanding of region-specific and population-specific vacci...
Conclusions: Despite the availability and broad use of pertussis containing vaccines in the setting of pregnancy and infants, use of these vaccines in Australian adults remains limited. These findings highlight a significant opportunity to improve awareness and uptake of pertussis containing vaccines in individuals with chronic respiratory disease.